Skip to main content
Caplight Logo









Toxys

Toxys

Private
OegstgeestHealthcare & Life Scienceshttps://toxys.com

Last Round

Grant

Dec 17, 2024

Total Funding Raised

$3.54M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Toxys is a biotechnology company that provides innovative in vitro toxicity screening solutions to identify hazardous properties of novel compounds for the pharmaceutical, chemical, cosmetics, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Compliance & Risk

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service, Government Contracts

AI Layer

Non-AI

Keywords

in vitro toxicologyanimal-free testinggenotoxicity assaymechanistic toxicologycontract research organizationCROToxTrackerpredictive toxicologyalternative to animal testingpreclinical toxicologyNew Approach MethodologiesNAMsstem cell-based assayreporter cell linesafety assessmenttoxicology assay kitdevelopmental toxicityReproTrackerDNA damage analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Toxys Comparables

Compare Toxys with similar companies based on industry and business-model similarity.

Toxys comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scantox Group
83%
intoDNA
77%
Emulate
74%

Toxys Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 17, 2024
Early FundingMar 10, 2020
GrantSep 21, 2016
Series AFeb 18, 2016

Key People

Founding team and executive leadership

Giel Hendriks

CEO

Executive Team

Remco Derr

Chief Operating Officer

Executive Team

Toxys Investors

Notable investors and investment history

Toxys investors
InvestorRounds
NC3RsGrant
EIT HealthGrant
KIKK CapitalEarly Funding
InnovationQuarterSeries A, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2026

    Signed an MoU with the Korean Institute of Toxicology (KIT).

Toxys Filings

Explore SEC and related filing metadata, where available.

Toxys filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Toxys's valuation, stock price, and market status.

Is Toxys a public or private company?

Toxys is a private company.

What is the current stock price of Toxys?

Toxys is a private company with no public stock price. No recent secondary market data is available.

How much is Toxys worth (valuation)?

Valuation information for Toxys is not publicly available.

Can I buy Toxys stock?

Toxys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Toxys's last funding round?

Toxys's most recent funding round was Grant on December 17, 2024.

Who are the main investors in Toxys?

Key investors in Toxys include NC3Rs, EIT Health, KIKK Capital, InnovationQuarter.

Will Toxys IPO soon?

No public IPO plans have been announced for Toxys.

How can I track Toxys secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Toxys's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOegstgeest
Employee Range38
Year Founded2014
Last FundingDec 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?